We estimated a risk of 95.4 cases of myopericarditis per million second doses administered in patients age 12-39 which is higher than the incidence reported to US advisory committees
95.4 per 1,000,000
9.54 per 100,000
0.954 per 10,000
My math is slightly off, but if this study is right, I'm not far off at all with my 1 in 10,000 estimate after two, which means the study is correct, which means after 10 doses, something around 20% of young men will have a ticking time bomb for a heart.
Turns out the reports of myocarditis in young men are being vastly UNDER-REPORTED because some facilities aren't properly labeling it for young men who are treated for it: https://www.medrxiv.org/content/10.1101/2021.12.21.21268209v1
95.4 per 1,000,000
9.54 per 100,000
0.954 per 10,000
My math is slightly off, but if this study is right, I'm not far off at all with my 1 in 10,000 estimate after two, which means the study is correct, which means after 10 doses, something around 20% of young men will have a ticking time bomb for a heart.
More Feminine Way indeed.